An Update on the Effects and Complications of BoNT-A in the Management of Third, Fourth, and Sixth Nerve Palsies: A Narrative Review
Bibliographic record
Abstract
This review article explores the etiology of oculomotor palsies-including third, fourth, and sixth cranial nerve palsies-and addresses the application of botulinum toxin type A (BoNT-A) in the management of these conditions, along with its associated complications and side effects. The objective is to assess BoNT-A's potential efficacy and its role across various types of nerve palsies. A comprehensive analysis of relevant studies reveals that BoNT-A holds promise as a therapeutic option in managing these conditions. BoNT-A injection into the lateral rectus muscle proves to be an effective treatment for addressing post-traumatic third nerve palsy. This is achieved by providing symptom relief and diminishing the necessity for subsequent surgical interventions. In the context of fourth nerve palsy, BoNT-A injection into the inferior oblique or inferior rectus muscles presents potential benefits but is accompanied by certain limitations. Additionally, previous studies have shown that BoNT-A injection into the antagonist medial rectus muscle for treatment of sixth nerve palsy results in favorable outcomes, such as contributing to functional improvement. The literature highlights the importance of timing, dosage, and grade of muscle dysfunction when administering BoNT-A injections. BoNT-A injection is an effective option to manage different types of cranial nerve palsies and improve binocular function. Furthermore, it plays an integral role in preventing antagonist muscle contracture and, hence, the need for future surgical intervention.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.003 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.004 | 0.003 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.001 | 0.002 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.005 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".